1. FDA, Guidance for Industry: Immediate Release Solid Oral Dosage Forms: Scale‐up and Post‐approval Changes: Chemistry, manufacturing and Controls, in vitro Dissolution Testing, and in vivo Bioequivalence documentation 1995.
2. FDA, Guidance for Industry: Extended Release Oral Dosage Forms: Development, Evaluation, and Application of in Vitro/in Vivo Correlations, 1997.
3. An investigation of in vitro/in vivo correlations for salbutamol nebulized by eight systems;Silkstone;J Aerosol Med,2002
4. The study of in vitro‐in vivo correlation: Pharmacokinetics and pharmacodynamics of salbutamol dry powder inhalers;Srichana;J Pharm Sci,2005
5. Neural network computer simulations of medical aerosols;Richardson;J Pharm Pharmacol,1996